Trial Profile
Dual-Hormone Closed-Loop Glucose Control in Type 1 Diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Aug 2022
Price :
$35
*
At a glance
- Drugs Glucagon (Primary) ; Insulin aspart (Primary)
- Indications Type 1 diabetes mellitus
- Focus Proof of concept; Therapeutic Use
- Acronyms Dual-Hormone Closed-Loop
- 29 May 2022 Status changed from recruiting to completed.
- 29 May 2022 Status changed from recruiting to completed.
- 16 Jul 2019 Status changed from discontinued to recruiting (EudraCT2019-001631-31).